BeStock  
Markets › Compare › XENE vs CRSP

XENE vs CRSP

Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.

vsvs
XENE · Xenon Pharmaceuticals$37.04 ▼ 1.38%
CRSP · CRISPR Therapeutics$39.10 ▲ 0.44%

One year, rebased to 100

Each line starts at 100 so growth is directly comparable

7096122148174Nov 24, '25May 26, '26Nov 20, '26
  • XENE -11.9%
  • CRSP -23.7%

Head to head

MetricXENECRSP
Price$37.04$39.10
Change today▼ 1.38%▲ 0.44%
Market cap$3.64B$3.79B
Return, 3 months-38.8%-31.5%
Return, year to date-17.4%-25.4%
Return, 1 year-10.0%-22.2%
P/E (TTM)––
P/B3.22.3
P/E percentile vs own 5y97th53rd
Dividend yield––
Revenue growth (YoY, latest qtr)–+1,325.1%
Net profit growth (YoY)-21.5%-4.7%
Gross margin–-676.9%
Operating margin–-2,221.7%
Net margin–-1,955.7%
Return on equity-50.3%-25.6%
Analyst target vs. price+98.2%+89.9%
Analyst buy share100%67%
RSI (14)4128
30-day volatility39.0%56.0%
Max drawdown, 1 year-52.8%-37.1%
Trend readStrong downtrendStrong downtrend
Analyst consensusBuyBuy

Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.

What the numbers say

  • CRSP is the largest of the group by market value.
  • XENE has returned the most over the past year.
  • XENE has been the calmest stock over the last 30 days.

Go deeper

Scroll to Top